Johnson & Johnson Price to Sales Ratio 2010-2025 | JNJ

Historical PS ratio values for Johnson & Johnson (JNJ) over the last 10 years. The current P/S ratio for Johnson & Johnson as of June 06, 2025 is . For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Johnson & Johnson P/S Ratio Historical Data
Date Stock Price TTM Sales per Share Price to Sales Ratio
2025-06-06 155.03 4.21
2025-03-31 164.43 $36.83 4.47
2024-12-31 142.26 $36.59 3.89
2024-09-30 158.14 $35.68 4.43
2024-06-30 141.55 $34.80 4.07
2024-03-31 151.97 $33.72 4.51
2023-12-31 149.45 $32.94 4.54
2023-09-30 147.32 $29.30 5.03
2023-06-30 155.43 $28.44 5.47
2023-03-31 144.47 $29.25 4.94
2022-12-31 163.47 $30.01 5.45
2022-09-30 150.20 $28.96 5.19
2022-06-30 162.12 $30.17 5.37
2022-03-31 160.83 $29.89 5.38
2021-12-31 154.25 $29.46 5.24
2021-09-30 144.68 $34.22 4.23
2021-06-30 146.71 $33.39 4.39
2021-03-31 145.45 $31.54 4.61
2020-12-31 138.42 $30.94 4.47
2020-09-30 130.04 $30.25 4.30
2020-06-30 122.02 $30.12 4.05
2020-03-31 113.00 $30.88 3.66
2019-12-31 124.90 $30.55 4.09
2019-09-30 110.02 $30.30 3.63
2019-06-30 117.56 $29.99 3.92
2019-03-31 117.19 $30.01 3.91
2018-12-31 107.47 $29.91 3.59
2018-09-30 114.34 $29.79 3.84
2018-06-30 99.74 $29.51 3.38
2018-03-31 104.57 $28.73 3.64
2017-12-31 113.28 $27.86 4.07
2017-09-30 104.77 $26.99 3.88
2017-06-30 105.93 $26.21 4.04
2017-03-31 99.08 $25.95 3.82
2016-12-31 91.04 $25.74 3.54
2016-09-30 92.71 $25.58 3.62
2016-06-30 94.57 $25.27 3.74
2016-03-31 83.76 $24.98 3.35
2015-12-31 78.94 $24.90 3.17
2015-09-30 71.22 $24.94 2.86
2015-06-30 73.79 $25.29 2.92
2015-03-31 75.61 $25.75 2.94
2014-12-31 78.05 $25.91 3.01
2014-09-30 79.04 $25.91 3.05
2014-06-30 77.06 $25.56 3.01
2014-03-31 71.85 $24.96 2.88
2013-12-31 66.52 $24.78 2.68
2013-09-30 62.52 $24.65 2.54
2013-06-30 61.46 $24.60 2.50
2013-03-31 57.93 $24.30 2.38
2012-12-31 49.41 $24.00 2.06
2012-09-30 48.15 $23.61 2.04
2012-06-30 46.78 $23.32 2.01
2012-03-31 45.23 $23.40 1.93
2011-12-31 44.58 $23.42 1.90
2011-09-30 42.89 $23.17 1.85
2011-06-30 44.40 $22.79 1.95
2011-03-31 39.21 $22.30 1.76
2010-12-31 40.56 $22.06 1.84
2010-09-30 40.29 $22.38 1.80
2010-06-30 38.04 $22.40 1.70
2010-03-31 41.62 $22.40 1.86
2009-12-31 40.80 $22.20 1.84
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $369.717B $88.821B
Johnson & Johnson's biggest strength is its diversified business model. It operates through pharmaceuticals, medical devices and consumer products divisions. Its diversification helps it to withstand economic cycles more effectively. J&J has one of the largest research and development (R&D) budget among pharma companies. J&J's worldwide business is divided into three segments: Pharmaceutical, Medical Devices and Consumer. The company has several drugs covering a broad range of areas such as neuroscience, cardiovascular & metabolism, immunology, oncology, pulmonary hypertension and infectious diseases and vaccines. The Medical Devices Segment offers products in the orthopedics, surgery, interventional solutions and vision markets. The Consumer Segment segment includes a broad range of products covering the areas of baby care, beauty/skin health, oral care, wound care and womens' health care, as well as over-the-counter (OTC) pharmaceutical products.
Stock Name Country Market Cap PE Ratio
Eli Lilly (LLY) United States $725.662B 55.65
AbbVie (ABBV) United States $331.148B 18.25
Roche Holding AG (RHHBY) Switzerland $259.965B 0.00
Novartis AG (NVS) Switzerland $248.822B 14.21
Merck (MRK) United States $194.906B 9.96
Pfizer (PFE) United States $131.446B 7.20
Sanofi (SNY) France $122.034B 12.02
Bayer (BAYRY) Germany $29.555B 6.02
Innoviva (INVA) United States $1.329B 13.93
Novo Nordisk (NVO) Denmark $0.000B 21.49